RECITALS:Stock Purchase Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • New York
DEFINITIONSLicense Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Ontario
447 March Road Tel: +1 613 592-2790 Ottawa, Ontario Fax: +1 613 592-6937 K2K 1X8 Canada www.mdsnordion.com (MDS NORDION LOGO) November 21, 2006 Wendy Graham-Coco Director, R&D Operations Molecular Insight Pharmaceuticals, Inc. 160 Second Street...Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
EXHIBIT 10.23 BMIPP Supply Agreement THIS AGREEMENT made in duplicate as of this 12th day of January, 2006. BETWEEN: MDS NORDION, a division of MDS (Canada) Inc. having a place of business at 447 March Road Ottawa, Ontario, Canada ("Nordion") AND:...Supply Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Ontario
RECITALS:Securities Purchase Agreement • February 1st, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
WITNESSETH:License Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
RECITALS:Registration Rights Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • New York
EXHIBIT 10.25 477 MARCH ROAD TEL: + 1 613 592 2790 OTTOWA, ON K2K 1X8 FAX: + 1 613 592 6937 CANADA www.mds.nordion.com (MDS NORDION LOGO) April 27, 2006 Molecular Insight Pharmaceuticals, Inc. 160 Second Street Cambridge, Massachusetts 202142 USA Dear...Development Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
First AmendmentLicense Agreement • January 30th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
MDS NORDION, a division of MDS (Canada) Inc. having a place of business at 447 March Road Ottawa, Ontario, Canada K2K1X8 ("Nordion")Confidentiality Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Ontario
RECITALS:Registration Rights Agreement • February 1st, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
EXHIBIT 10.24 THIS AGREEMENT made in duplicate as of the 22 day of March, 2006, BETWEEN: MDS NORDION, a division of MDS (Canada) Inc. a corporation incorporated under the laws of Canada having a place of business at 447 March Road, Kanata, Ontario,...Collaboration Agreement • December 8th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Ontario
Exhibit 10.3 AMENDED AND RESTATED VOTING AGREEMENT THIS AMENDED AND RESTATED VOTING AGREEMENT is dated as of March 29, 2005 by and among Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the "Company"), the holders of the Company's...Voting Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • Massachusetts
Exhibit 10.17 EXCLUSIVE LICENSE AGREEMENT THIS AGREEMENT made as of September 5th, 2003. BETWEEN: MOLECULAR INSIGHT PHARMACEUTICALS, INC. F/K/A BIOSTREAM, INC. a corporation incorporated under the laws of the State of Massachusetts, and having a place...Exclusive License Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • Ontario
WITNESSETH:Employment Agreement • April 2nd, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
TEN COM - as tenants in common UNIF GIFT MIN ACT- ____________ Custodian ____________ TEN ENT - as tenants by the (Cust) (Minor) entireties JT TEN - as joint tenants with under Uniform Gifts to Minors right of survivorship Act ________________ and not...Stock Certificate • January 22nd, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
transferable on the books of the Corporation by the holder hereof in person or by duly authorized Attorney, upon surrender of this Certificate, properly endorsed. This Certificate and the shares represented hereby are issued under and shall be held subject to the laws of the Commonwealth of Massachusetts and the Articles of Organization and By-Laws of the Corporation and all amendments thereto, copies of which are on file with the Transfer Agent, to all of which the holder of this Certificate assents by acceptance hereof.
Exhibit 10.36 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 to the Employment Agreement is made as of the 14th day of November, 2005 by and among Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the "Employer"), and...Employment Agreement • February 1st, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
EXHIBIT 10.30 TECHNOLOGY TRANSFER AGREEMENT THIS TECHNOLOGY TRANSFER AGREEMENT (the "Agreement") is entered into effective as of the 20th day of December 2006 (the "Effective Date"), by and between Mallinckrodt Inc., a Delaware corporation, with a...Technology Transfer Agreement • January 30th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Exhibit 10.6 GREENWORKS MOLECULAR INSIGHT PHARMACEUTICALS LEASE 1. DATE OF LEASE: June 19, 2003 2. LANDLORD: RayJoe Limited Partnership, a Massachusetts limited partnership, which expression shall include its heirs, executors, administrators,...Lease Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc.
WITNESSETH:Employment Agreement • January 19th, 2006 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
1. BACKGROUNDExclusive License Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • District of Columbia
RECITALS:Investor Rights Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • New York
BACKGROUNDLicense, Development and Commercialization Agreement • January 30th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
WITNESSETH:Employment Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • Massachusetts
RECITALS:Contract of Purchase and Sale • May 17th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Texas
FACILITY SETUP AND CONTRACT MANUFACTURING AGREEMENT between Eckert & Ziegler Nuclitec GmbH Gieselweg 1 38110 Braunschweig Germany - hereinafter referred to as EZN - and Molecular Insight Pharmaceuticals, Inc Cambridge, MA 02142 USA - hereinafter...Facility Setup and Contract Manufacturing Agreement • March 10th, 2010 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
INVESTMENT AGREEMENT dated as of December 9, 2010 between MOLECULAR INSIGHT PHARMACEUTICALS, INC. and SAVITR CAPITAL LLCInvestment Agreement • December 14th, 2010 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS INVESTMENT AGREEMENT (together with all exhibits and schedules hereto and as the same may be amended, supplemented or otherwise modified from time to time in accordance with the terms hereof, the “Agreement”), dated as of December 9, 2010, by and among Savitr Capital LLC, a Delaware limited liability company (the “Investor”) and Molecular Insight Pharmaceuticals, a Massachusetts corporation (the “Company”) and its successors, including, as the context may require, on or after the Effective Date, as reorganized pursuant to the Bankruptcy Code.
CHANGE OF CONTROL AGREEMENTChange of Control Agreement • March 26th, 2010 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This CHANGE OF CONTROL AGREEMENT, made as of March 22, 2010, is by and between Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the “Company”), and Charles H. Abdalian, Jr. (the “Employee”). All references to the Company include all affiliated or subsidiary entities including, without limitation, a Buyer in a Change of Control (each as defined below).
SECURITY AGREEMENTSecurity Agreement • May 4th, 2011 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
SECURITY AGREEMENT, dated as of April 28, 2011, made by Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation (the “Grantor”), in favor of NexBank SSB, a Texas-chartered savings bank (“NexBank”), as collateral agent (in such capacity, together with its successors and assigns in such capacity, the “Collateral Agent”) acting pursuant to this Agreement for the benefit of the Secured Parties (as defined in the Credit Agreement referred to below).
andUnit Purchase Agreement • November 8th, 2005 • Molecular Insight Pharmaceuticals, Inc. • Massachusetts
GREENWORKS MOLECULAR INSIGHT PHARMACEUTICALS LEASELease Agreement • May 8th, 2008 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
SEVENTH AMENDMENT TO MOLECULAR INSIGHT PHARMACEUTICALS, INC., GREENWORKS LEASELease Agreement • January 25th, 2008 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, RayJoe Limited Partnership (“Landlord”) and Molecular InSight Pharmaceuticals, Inc., (“Tenant”), confirm the following facts and their agreement as follows:
EMPLOYMENT AGREEMENT (for Donald Wallroth)Employment Agreement • September 11th, 2007 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
THIS EMPLOYMENT AGREEMENT (this “Agreement”), effective as of August 13, 2007 (the “Effective Date”), is made by and between Molecular Insight Pharmaceuticals, Inc., a Massachusetts corporation having its principal place of business at 160 Second Street, Cambridge, Massachusetts 02142 (the “Employer”), and Donald Wallroth (the “Employee”).
LEASE AGREEMENTLease Agreement • May 8th, 2008 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS LEASE AGREEMENT (the “Lease”) is dated as of April 25, 2008, between ARE-MA REGION NO. 35, LLC, a Delaware limited liability company (“Landlord”), and MOLECULAR INSIGHT PHARMACEUTICALS, INC., a Massachusetts corporation (“Tenant”).
SECOND AMENDMENT TO LEASELease Agreement • May 6th, 2010 • Molecular Insight Pharmaceuticals, Inc. • Pharmaceutical preparations
This Second Amendment to Lease (the “Second Amendment”) is made as of March 30, 2010, by and between ARE-MA REGION NO. 35, LLC, a Delaware limited liability company, having an address at 385 East Colorado Boulevard, Suite 299, Pasadena, CA 91101 (“Landlord”), and MOLECULAR INSIGHT PHARMACEUTICALS, INC., a Massachusetts corporation, having an address at 160 Second Street, Cambridge, MA 02142 (“Tenant”).
